Bodyport is redefining heart-failure care by enabling early, in-home detection of congestion in a single step. Our solution pairs the Bodyport Cardiac Scale, which non-invasively measures key hemodynamic biomarkers, with the Congestion Index — an advanced algorithm that has been shown to detect worsening heart failure. Delivered through a connected software platform, these insights can help care teams intervene earlier and support better disease management.
With a single step, the FDA-cleared Bodyport Cardiac Scale measures hemodynamics through a patient’s feet and transmits the data over a cellular connection to the care team within minutes. Advanced sensors and proprietary algorithms non-invasively measure a wide range of metrics, providing a comprehensive view of heart function and fluid status from home.
The Bodyport Congestion Index combines multiple hemodynamic biomarkers captured by the Cardiac Scale into a single composite metric to help accurately detect early signs of worsening heart failure. In clinical study, the Congestion Index detected 70% of heart failure events — twice as many as standard weight-based rules — while generating fewer false alerts. This can support earlier identification of worsening status while helping reduce alert fatigue.
The Congestion Index detects events that weight misses.
Bodyport’s care platform connects a powerful clinical portal with an intuitive patient app to deliver timely, actionable insights. Clinicians receive clear signals to help guide care, while patients benefit from a simple, supportive at-home experience. A robust API enables seamless integration with leading EHRs and third-party systems, and full support for RPM billing makes reimbursement straightforward. The platform also tracks patient engagement and automatically documents clinical activities for compliance, all within a fully HIPAA-compliant, SOC 2-certified system.
The Bodyport solution has been rigorously validated through multiple studies published in leading peer-reviewed medical journals. Our commitment to evidence and clinical rigor guides every aspect of our work, from sensor development to algorithm design to patient experience. We partner with top health systems and researchers to ensure our technology meets the highest scientific standards and delivers meaningful, reliable insights that truly improve patient care.
In a clinical study*, Bodyport significantly outperformed traditional weight-based monitoring:
Fudim M, Egolum U, Haghighat A, Kottam A, Sauer AJ, Shah H, Kumar P, Rakita V, Lopes RD, Centen C, Ozonat K. Surveillance and alert-based multiparameter monitoring to reduce worsening heart failure events: results from SCALE-HF 1. Journal of Cardiac Failure. 2025 Apr 1;31(4):661-75.
